FDA Approved: BRINEURA — Original Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

FDA approves Brineura (cerliponase alfa) through the original Biologics License Application by BioMarin for the treatment of neuronal ceroid lipofuscinosis type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuronal Ceroid Lipofuscinosis Type

Drugs mentioned

• BRINEURA (cerliponase alfa)

Snippet

ORIG AP for BRINEURA (CERLIPONASE ALFA)